Bent Pedersen

1.6k total citations
63 papers, 1.2k citations indexed

About

Bent Pedersen is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bent Pedersen has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 21 papers in Genetics and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bent Pedersen's work include Acute Myeloid Leukemia Research (31 papers), Chronic Myeloid Leukemia Treatments (30 papers) and Acute Lymphoblastic Leukemia research (21 papers). Bent Pedersen is often cited by papers focused on Acute Myeloid Leukemia Research (31 papers), Chronic Myeloid Leukemia Treatments (30 papers) and Acute Lymphoblastic Leukemia research (21 papers). Bent Pedersen collaborates with scholars based in Denmark, Hungary and United Kingdom. Bent Pedersen's co-authors include Peter Hokland, Niels Pallisgaard, Poul Jørgensen, Gitte Kerndrup, Jørgen Ellegaard, F. G. J. Hayhoe, Knud Bendix‐Hansen, Niels Clausen, Jan Maxwell Nørgaard and Lars Munksgaard and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Clinical Chemistry.

In The Last Decade

Bent Pedersen

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bent Pedersen Denmark 17 654 362 308 307 182 63 1.2k
Y Carcassonne France 17 399 0.6× 179 0.5× 177 0.6× 189 0.6× 174 1.0× 115 1.1k
Jana Březinová Czechia 20 486 0.7× 300 0.8× 280 0.9× 283 0.9× 133 0.7× 94 1.1k
M. A. Boogaerts Belgium 20 823 1.3× 266 0.7× 135 0.4× 262 0.9× 66 0.4× 29 1.2k
T. de Witte Netherlands 23 875 1.3× 254 0.7× 228 0.7× 266 0.9× 119 0.7× 54 1.4k
Hiroto Miwa Japan 22 859 1.3× 693 1.9× 435 1.4× 215 0.7× 217 1.2× 44 1.5k
W. J. Mitus United States 21 422 0.6× 280 0.8× 178 0.6× 382 1.2× 61 0.3× 37 1.2k
Jin Takeuchi Japan 22 987 1.5× 448 1.2× 605 2.0× 344 1.1× 306 1.7× 94 1.7k
Philippe Moulin Belgium 19 285 0.4× 252 0.7× 164 0.5× 175 0.6× 71 0.4× 46 935
Shinjiro Todo Japan 21 721 1.1× 258 0.7× 213 0.7× 88 0.3× 91 0.5× 79 1.4k
JW Fay United States 18 482 0.7× 212 0.6× 164 0.5× 245 0.8× 313 1.7× 38 1.4k

Countries citing papers authored by Bent Pedersen

Since Specialization
Citations

This map shows the geographic impact of Bent Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bent Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bent Pedersen more than expected).

Fields of papers citing papers by Bent Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bent Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bent Pedersen. The network helps show where Bent Pedersen may publish in the future.

Co-authorship network of co-authors of Bent Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Bent Pedersen. A scholar is included among the top collaborators of Bent Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bent Pedersen. Bent Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smedby, Karin E., Henrik Hjalgrim, Mads Melbye, et al.. (2005). Ultraviolet Radiation Exposure and Risk of Malignant Lymphomas. JNCI Journal of the National Cancer Institute. 97(3). 199–209. 178 indexed citations
2.
Serakıncı, Nedime, Mette Østergaard, Herdis Larsen, et al.. (2002). Multiple telomeric aberrations in a telomerase-positive leukemia patient. Cancer Genetics and Cytogenetics. 138(1). 11–16. 2 indexed citations
3.
Nørgaard, Jan Maxwell, Lene Olesen, G. Olesen, et al.. (2001). FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara‐C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia. European Journal Of Haematology. 67(4). 221–229. 11 indexed citations
4.
Pedersen, Bent, Jan Maxwell Nørgaard, Bjarne Bach Pedersen, et al.. (2000). Many unbalanced translocations show duplication of a translocation participant. Clinical and cytogenetic implications in myeloid hematologic malignancies. American Journal of Hematology. 64(3). 161–169. 1 indexed citations
6.
Pedersen, Bent, Claus L. Andersen, Jan Maxwell Nørgaard, et al.. (1998). Trisomy 10 Survival: A Literature Review and Presentation of Seven New Cases. Cancer Genetics and Cytogenetics. 103(2). 130–132. 7 indexed citations
8.
Pedersen, Bent. (1997). MDS and AML with trisomy 8 as the sole chromosome aberration show different sex ratios and prognostic profiles: A study of 115 published cases. American Journal of Hematology. 56(4). 224–229. 2 indexed citations
9.
Ørntoft, Torben F., Peter Meldgaard, Bent Pedersen, & Hans Wolf. (1996). The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines.. PubMed. 56(5). 1031–36. 40 indexed citations
10.
Pedersen, Bent & Jørgen Ellegaard. (1994). A factor encoded by 7q31 suppresses expansion of the 7q- clone and delays cytogenetic progression. Cancer Genetics and Cytogenetics. 78(2). 181–188. 24 indexed citations
11.
Pedersen, Bent, Claus R. Bartram, & Johan Lanng Nielsen. (1992). Ph‐positive chronic myeloid leukemia with loss of the segment distal to M‐bcr. Genes Chromosomes and Cancer. 4(1). 92–93. 1 indexed citations
12.
13.
Pedersen, Bent, et al.. (1981). Erythroblastic transformation of chronic myeloid leukemia: Hyperdiploid Ph1-positive karyotypes in primitive PAS-positive erythroblasts. Annals of Hematology. 42(6). 345–354. 3 indexed citations
14.
Pedersen, Bent. (1979). Spleen and Relapse in Chronic Myeloid Leukaemia. Scandinavian Journal of Haematology. 22(5). 369–374. 4 indexed citations
15.
Pedersen, Bent. (1973). Periodic Acid‐Schiff Positive Myeloblasts in Chronic Myelogenous Leukaemia: Relation to Karyotype Evolution. Scandinavian Journal of Haematology. 11(2). 112–121. 6 indexed citations
16.
Pedersen, Bent. (1973). THE BLASTIC CRISIS OF CHRONIC MYELOID LEUKAEMIA: ACUTE TRANSFORMATION OF A PRELEUKAEMIC CONDITION?. British Journal of Haematology. 25(2). 141–145. 20 indexed citations
17.
Pedersen, Bent. (1971). Relation between Karyotype and Cytology in Chronic Myelogenous Leukaemia. Scandinavian Journal of Haematology. 8(6). 494–504. 5 indexed citations
18.
Pedersen, Bent. (1968). Influence of Hyperdiploidy on Ph1 Prevalence Response to Therapy in Chronic Myelogenous Leukaemia. British Journal of Haematology. 14(5). 507–512. 6 indexed citations
19.
Pedersen, Bent. (1966). KARYOTYPE PROFILES IN CHRONIC MYELOGENOUS LEUKAEMIA. INFLUENCE OF THERAPY AND PROGRESSION OF DISEASE. Acta Pathologica Microbiologica Scandinavica. 67(4). 463–478. 14 indexed citations
20.
Pedersen, Bent. (1966). THE ANEUPLOID, Ph1‐POSITIVE CELL POPULATION DURING PROGRESSION AND TREATMENT OF CHRONIC MYELOGENOUS LEUKAEMIA. Acta Pathologica Microbiologica Scandinavica. 67(4). 451–462. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026